TCT 2010 schedule

Here is the page we will use to coordinate the TV events at TCT 2010. The filming will take place in our open studio on the 3rd floor of the convention center right outside the Main Arena (Ballroom A,B,C.) Open time slots are indicated below in red.

---

Click on Date for Detailed Schedule

Wednesday September 22, 2010

Thursday September 23, 2010

Friday September 24, 2010

Tuesday September 25, 2010

---

Wednesday September 22, 2010

2:00 PM

2:00 PM - 2:30 PM

• Interviewee: Dr. Thomas Zeller
• Trial: DES-BTK: A Prospective, Double-Blind, Randomized Trial of Polymer-Free Sirolimus-Eluting Stents Compared to Bare Metal Stents in Patients with Infrapopliteal Disease
• Embargo lift: 12 PM on Friday September 24th

2:30 PM

2:30 PM - 3:00 PM

• Interviewee: Dr. Jean-Philippe Collet
• Trial: CLOVIS-2: A Prospective, Randomized, Nested Case-Control Crossover Study of a High vs. Low Clopidogrel Loading Dose in Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele
• Embargo lift: 7 PM on Wednesday September 22nd

3:00 PM

3:00 PM - 3:30 PM

• Interviewee: Dr. Martin Leon
• Trial: PARTNER: A Prospective Randomized Trial of Transcatheter Aortic Valve Implantation Compared to Standard Therapy in Patients with Inoperable Aortic Stenosis
• Embargo lift: 11 AM on Thursday September 23rd

3:30 PM

3:30 PM - 4:00 PM

• Interviewee: Dr. Robert-Jan van Geuns
• Trial: APPOSITION II: A Prospective Randomized Trial of Self-Expanding vs. Balloon Expandable Stents in Patients with Acute Myocardial Infarction
• Embargo lift: 6:45 PM on Wednesday September 22nd

4:00 PM

4:00 PM - 4:30 PM

• Interviewee: Dr. Gennaro Sardella
• Trial: ROMA: A Prospective Randomized Trial of Rosuvastatin Pretreatment Prior to Percutaneous Coronary Intervention
• Embargo lift: 7:45 PM on Tuesday Sepetember 21st

4:30 PM

4:30 PM - 5:00 PM

• Interviewee: Dr. Elvin Kedhi
• Trial: COMPARE-AMI: Two-Year Outcomes from a Prospective Randomized Trial of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents in Patients with STEMI
• Embargo lift: 7:30 PM on Friday September 24th

5:00 PM

5:00 PM - 5:30 PM

• Interviewee: Dr. Giuseppe De Luca
• Trial: PREVENT-ICARUS: A Prospective, Randomized, Double-Blind Trial of Intracoronary Adenosine to Prevent Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Angioplasty
• Embargo lift: 6:45 PM on Friday September 24th

6:40 PM

6:40 PM - 7:00 PM

• Interviewee: Dr.Gregg W. Stone
• Trial: SPIRIT IV: Two-Year Results from a Prospective Randomized Trial of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease. AND HORIZONS-AMI: Three-Year Follow-up from a Prospective Randomized Trial of Antithrombin Strategies and Drug-Eluting Stents in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty
• Embargo lift: 11:24 AM on Thursday September 23rd (SPIRIT IV) AND 11:24 on Saturday September 25th

Return to top

Thursday September 23, 2010

9:45 AM

9:45AM - 10:15 AM

• Interviewee: Dr. Rajesh M. Dave
• Trial: CRYSTAL AMI: A Prospective Randomized Trial of Intracoronary Site-Specific Abciximab Compared to Intravenous Abciximab in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty
• Embargo lift: 7:00 PM on Friday September 24th

10:15 AM

10:15AM - 10:45 AM

• Interviewee: Dr. Dimitrios Alexopoulos
• Trial: PRO-GR: A Prospective, Randomized, Crossover Study of Maintenance High-Dose Clopidogrel vs. Prasugrel in Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele
• Embargo lift: 7:15 PM on Wednesday September 22nd

10:45 AM

OPEN TIME SLOT

11:15 AM

11:15AM - 11:45 AM

• Interviewee: Dr. Eberhard Grube
• Trial: BIOFREEDOM: A Prospective Randomized Trial of Polymer-Free Biolimus A9-Eluting Stents and Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease
• Embargo lift: 12:00 PM on Saturday September 25th

1:00 PM

1:00 PM - 1:20 PM

• Interviewee: Dr. Shmuel Banai
• Trial: BLAST: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of a Monocyte-Depleting Agent After Bare Metal Stents in Patients with Coronary Artery Disease
• Embargo lift: 12:30 PM on Friday September 24th

1:20 PM

1:20 PM - 1:50 PM

• Interviewee: Dr. Bernhard Meier
• Trial: PFO Closure: A Prospective, Nonrandomized, Propensity-Adjusted Study of PFO Closure Compared to Medical Therapy in Patients with Stroke Presumably Related to PFO
• Embargo lift: 7:45 PM on Wednesday September 22nd

3:30 PM

OPEN TIME SLOT

3:50 PM

3:50 PM - 4:10 PM

• Interviewee: Dr. Jochen Wöhrle
• Trial: PERfECT STENT: A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease
• Embargo lift: 12:30 PM on Thursday September 23rd

Return to top

Friday September 24, 2010

1:00 PM

OPEN TIME SLOT

1:30 PM

OPEN TIME SLOT

2:00 PM

2:00 PM - 2:30 PM

• Interviewee: Dr. Julinda Mehilli
• Trial: ISAR-TEST-5: A Prospective Randomized Trial of Polymer-Free Sirolimus-/Probucol-Eluting Stents Compared to Zotarolimus-Eluting Stents in Patients with Coronary Artery Disease
• Embargo lift: 11:00 AM on Saturday September 25th

2:30 PM

2:30 PM - 3:00 PM

• Interviewee: Dr. Martyn R. Thomas
• Trial: SOURCE TAVI Cohort 2: A Prospective Observational Study of More Than 2,300 Lower Risk and "Valve-in-Valve" Patients Undergoing Transcatheter Aortic Valve Implantation
• Embargo lift: 7:30 PM on Wednesday September 22nd

3:00 PM

3:00 PM - 3:30 PM

• Interviewee: Dr. Robert A. Byrne
• Trial: ISAR-TEST-4: Two-Year Clinical and Angiographic Outcomes from a Prospective Randomized Trial of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
• Embargo lift: 11:42 AM on Friday September 24th

3:30 PM

3:30 PM - 4:00 PM

• Interviewee: Dr. Mohsen Sharifi
• Trial: TORPEDO: A Prospective Randomized Trial of Percutaneous Endovenous Intervention Compared to Anticoagulation Alone in Patients with Deep Venous Thrombosis
• Embargo lift: 12:15 PM on Friday September 24th

4:00 PM

4:00 PM - 4:30 PM

• Interviewee: Dr. Michelle O'Donoghue
• Trial: LANCELOT ACS: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of a Reversible PAR-1 Thrombin Receptor Antagonist in Patients with Acute Coronary Syndromes
• Embargo lift: 12:00 PM on Thursday September 23rd

4:30 PM

4:30 PM - 5:00 PM

• Interviewee: Dr. Michael D. Dake
• Trial: ZILVER PTX: A Prospective Randomized Trial of a Paclitaxel-Eluting Stent Compared to Balloon Angioplasty with Provisional Bare Metal Stenting in Patients with Superficial Femoral Artery Disease
• Embargo lift: 11:00 AM on Friday September 24th

5:00 PM

5:00 PM - 5:30 PM

• Interviewee: Dr. Antonio Colombo
• Trial:AVIO: A Prospective Randomized Trial of Intravascular Ultrasound-Guided Compared to Angiography-Guided Stent Implantation in Complex Coronary Lesions
• Embargo lift: 12:15 PM on Saturday September 25th

Return to top

Saturday September 25, 2010

10:30 AM

10:30 AM - 11:00 AM

• Interviewee: Dr. Bernard R. Chevalier
• Trial: CRISTAL: A Prospective Randomized Trial of Sirolimus-Eluting Stents Compared to Balloon Angioplasty for Restenosis of Drug-Eluting Coronary Stents
• Embargo lift: 11:42 AM on Saturday September 25th

11:00 AM

11:00 AM - 11:30 AM

• Interviewee: Dr. Antonio L. Bartorelli
• Trial: MYTHOS: A Prospective Randomized Trial of Furosemide-Induced High-Volume Diuresis with Matched Hydration Using a Dedicated Device to Prevent Contrast Nephropathy
• Embargo lift: 6:15 PM on Friday September 24th

11:30 AM

11:30 AM - 12:00 PM

• Interviewee: Dr. Dominick J Angiolillo
• Trial: SWAP Trial
• Embargo lift:

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

1:00 PM - 1:30 PM

• Interviewee: Dr. Hyo-Soo Kim
• Trial: EXCELLENT: A Prospective Randomized Trial of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
• Embargo lift: 12:30 PM on Saturday September 25th

Return to top